Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-252195
Filing Date
2024-11-06
Accepted
2024-11-06 17:11:37
Documents
6
Effectiveness Date
2024-11-06

Document Format Files

Seq Description Document Type Size
1 S-8 d907947ds8.htm S-8 54850
2 EX-5.1 d907947dex51.htm EX-5.1 6961
3 EX-23.1 d907947dex231.htm EX-23.1 3231
4 EX-FILING FEES d907947dexfilingfees.htm EX-FILING FEES 16475
5 GRAPHIC g907947g1105081535377.jpg GRAPHIC 2408
6 GRAPHIC g907947g30h78.jpg GRAPHIC 8313
  Complete submission text file 0001193125-24-252195.txt   97668
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-283039 | Film No.: 241432172
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)